← Scroll for more →
Xeris Biopharma Holdings, Inc. (XERS)
Pharmaceutical Preparations
Latest Price
$10.75
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
0.08
P/B Ratio
140.89
Institutional Ownership
62.5% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 14.53M | $115.0M | 8.37% | +1.58M | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 7.80M | $61.0M | 4.50% | +15.9K | 2026-06-30 |
| Vanguard Capital Management LLC | 7.34M | $58.0M | 4.23% | -- | 2026-06-30 |
| State Street Corp | 4.82M | $38.0M | 2.78% | +163.4K | 2026-06-30 |
| Geode Capital Management, LLC | 4.72M | $37.0M | 2.72% | +427.6K | 2026-06-30 |
| Nuveen, LLC | 4.39M | $34.0M | 2.53% | +1.47M | 2026-06-30 |
| Rosalind Advisors, Inc. | 2.91M | $23.0M | 1.68% | -322.7K | 2026-06-30 |
| Qube Research & Technologies Ltd | 2.89M | $22.0M | 1.67% | -1.22M | 2026-06-30 |
| Vanguard Portfolio Management LLC | 2.63M | $20.0M | 1.51% | -- | 2026-06-30 |
| Wellington Management Group LLP | 2.37M | $18.0M | 1.36% | +193.7K | 2026-06-30 |